Analyst
ING
Equibles does not estimate personal net worth.
Stijn De Meester is recorded as Analyst at ING. Stijn De Meester has spoken on 1 earnings call across 1 company, most recently for Fagron on July 30, 2026. The companies whose calls Stijn De Meester spoke on are classified in the Healthcare sector.
“The PCAC hearing showed that support for these peptides is not unanimous, given these drugs often lack some medical evidence and burden to self-medication. Nevertheless, the drive from the industry to grow this segment seems very strong.”
ING
Analyst
Transcript header (unverified)
Fagron
Drug Manufacturers - Specialty & Generic · Healthcare
Fagron H1 2026 Results Call
Fagron
